Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#81 / 200 Total
BRNS - Barinthus Biotherapeutics Plc. ADR - Stock Price Chart
TickerBRNS [NASD]
CompanyBarinthus Biotherapeutics Plc. ADR
CountryUnited Kingdom
IndustryBiotechnology
Market Cap30.57MEPS (ttm)-1.55
P/E-EPS this Y10.11%
Forward P/E-EPS next Y-5.86%
PEG-EPS past 5Y-
P/S2.02EPS next 5Y-0.43%
P/B0.24EPS Q/Q-12.88%
Dividend-Sales Q/Q-
Insider Own9.11%Inst Own15.32%
Insider Trans0.00%Inst Trans0.78%
Short Float0.04%EarningsMar 20/b
Analyst Recom1.00Target Price4.50
Avg Volume31.30K52W Range0.79 - 4.16
Barinthus Biotherapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development of antigen-specific immunotherapeutics that induce T cells to treat chronic viral infections, autoimmune diseases, and cancer. It also focuses on the pipeline of both clinical and preclinical stage therapeutic, and prophylactic programs. The company was founded by Adrian Hill and Dame Sarah Gilbert in March 2021 and is headquartered in Didcot, the United Kingdom.
NGNE - Neurogene Inc - Stock Price Chart
TickerNGNE [NASD, RUT]
CompanyNeurogene Inc
CountryUSA
IndustryBiotechnology
Market Cap156.16MEPS (ttm)-4.60
P/E-EPS this Y-7.96%
Forward P/E-EPS next Y-12.04%
PEG-EPS past 5Y-10.74%
P/S167.91EPS next 5Y-8.29%
P/B0.50EPS Q/Q-8.67%
Dividend-Sales Q/Q-
Insider Own17.51%Inst Own93.70%
Insider Trans4.63%Inst Trans55.45%
Short Float17.71%EarningsMar 24/a
Analyst Recom1.14Target Price50.20
Avg Volume241.48K52W Range9.59 - 74.49
Neurogene, Inc. is a clinical-stage biotechnology company, which engages in the development of product portfolio of genetic medicines for rare neurological diseases. The company was founded in May 2007 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Cvijic Christine MikailPresident and CFOMar 13 '25Sale16.944,50176,24772,343Mar 17 05:14 PM
Samsara BioCapital GP, LLC10% OwnerNov 26 '24Buy25.8348,7701,259,6231,717,127Nov 27 04:39 PM
Cvijic Christine MikailPresident and CFONov 22 '24Buy20.4824,000491,40076,844Nov 25 09:29 PM
McMinn RachelChief Executive OfficerNov 22 '24Buy20.4047,500969,0001,297,859Nov 25 09:29 PM
DHX - DHI Group Inc - Stock Price Chart
TickerDHX [NYSE]
CompanyDHI Group Inc
CountryUSA
IndustrySoftware - Application
Market Cap62.10MEPS (ttm)0.00
P/E300.00EPS this Y66.67%
Forward P/E40.50EPS next Y99.99%
PEG-EPS past 5Y-52.96%
P/S0.44EPS next 5Y-
P/B0.57EPS Q/Q-53.73%
Dividend-Sales Q/Q-6.71%
Insider Own16.45%Inst Own66.31%
Insider Trans-0.36%Inst Trans-6.01%
Short Float0.36%EarningsFeb 05/a
Analyst Recom1.00Target Price4.88
Avg Volume187.81K52W Range1.31 - 3.32
DHI Group, Inc. engages in the provision of artificial intelligence-powered software products, online tools, and talent acquisition services, delivering career marketplaces to candidates for technology-focused roles and employers hiring tech talent globally. The company was founded in 1990 and is headquartered in Centennial, CO.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LESSER EVANOfficerFeb 28 '25Proposed Sale2.221,5003,330Feb 28 04:30 PM
Swann Kathleen M.DirectorFeb 12 '25Sale2.9610,00029,600118,113Feb 13 04:33 PM
LESSER EVANOfficerFeb 13 '25Proposed Sale3.253,0009,750Feb 13 04:12 PM
Swann Kathleen M.DirectorFeb 12 '25Proposed Sale2.9610,00029,630Feb 12 04:13 PM
LESSER EVANOfficerFeb 06 '25Proposed Sale3.003,0009,000Feb 06 04:11 PM
ONVO - Organovo Holdings Inc - Stock Price Chart
TickerONVO [NASD]
CompanyOrganovo Holdings Inc
CountryUSA
IndustryBiotechnology
Market Cap3.65MEPS (ttm)-10.35
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y19.06%
P/S30.39EPS next 5Y-
P/B8.39EPS Q/Q51.72%
Dividend-Sales Q/Q380.00%
Insider Own1.67%Inst Own12.21%
Insider Trans0.00%Inst Trans-
Short Float3.37%EarningsNov 07
Analyst Recom3.00Target Price64.80
Avg Volume663.84K52W Range2.13 - 21.96
Organovo Holdings, Inc. is engaged in the development of bioprinted human tissues that emulate human biology and disease. Its three-dimensional human tissue platform is enabled by its proprietary NovoGen Bioprinters and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company was founded on January 30, 2012 and is headquartered in San Diego, CA.
VTYX - Ventyx Biosciences Inc - Stock Price Chart
TickerVTYX [NASD, RUT]
CompanyVentyx Biosciences Inc
CountryUSA
IndustryBiotechnology
Market Cap75.40MEPS (ttm)-1.99
P/E-EPS this Y-2.09%
Forward P/E-EPS next Y6.84%
PEG-EPS past 5Y-87.13%
P/S-EPS next 5Y11.01%
P/B0.30EPS Q/Q47.62%
Dividend-Sales Q/Q-
Insider Own14.00%Inst Own78.63%
Insider Trans6.36%Inst Trans3.37%
Short Float11.30%EarningsFeb 27/a
Analyst Recom1.50Target Price8.67
Avg Volume1.25M52W Range1.07 - 5.66
Ventyx Biosciences, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing novel small molecule therapeutics for the treatment of autoimmune diseases. Its clinical stage pipeline includes VTX958, a Phase 1 allosteric TYK2 inhibitor for the treatment of a broad range of autoimmune diseases, VTX002, a Phase 2-ready S1P1 receptor modulator for the treatment of ulcerative colitis, and VTX2735, a Phase 1-ready peripheral inhibitor of the NLRP3 inflammasome, which is a mediator of multiple inflammatory conditions. The company was founded on November 21, 2018 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mohan RajuCEO AND PRESIDENTMar 28 '25Option Exercise0.0011,84402,303,540Apr 01 04:36 PM
Nuss JohnCHIEF SCIENTIFIC OFFICERMar 28 '25Option Exercise0.004,5310469,113Apr 01 04:35 PM
Nuss JohnCHIEF SCIENTIFIC OFFICERDec 27 '24Sale2.3621,11949,841464,582Dec 30 05:33 PM
Nuss JohnOfficerDec 27 '24Proposed Sale2.3621,11949,842Dec 27 04:46 PM
Gujrathi SheilaDirectorDec 23 '24Buy2.31130,000300,573130,000Dec 26 08:05 PM
BMEA - Biomea Fusion Inc - Stock Price Chart
TickerBMEA [NASD, RUT]
CompanyBiomea Fusion Inc
CountryUSA
IndustryBiotechnology
Market Cap81.16MEPS (ttm)-3.84
P/E-EPS this Y43.64%
Forward P/E-EPS next Y14.36%
PEG-EPS past 5Y-149.32%
P/S-EPS next 5Y20.08%
P/B1.50EPS Q/Q16.92%
Dividend-Sales Q/Q-
Insider Own12.70%Inst Own62.52%
Insider Trans0.00%Inst Trans-1.83%
Short Float31.64%EarningsMar 31/a
Analyst Recom1.57Target Price19.50
Avg Volume653.33K52W Range1.94 - 14.43
Biomea Fusion, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic disorders, such as diabetes. It offers its lead product candidate, BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers. The company was founded by Thomas Butler and Ramses Erdtmann in August 2017 and is headquartered in Redwood City, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hitchcock Michael J.M.DirectorSep 30 '24Buy10.0610,000100,60015,000Oct 01 04:30 PM
Valle FrancoChief Financial OfficerJun 11 '24Buy4.4312,50955,36142,500Jun 12 04:30 PM
KWE - KWESST Micro Systems Inc - Stock Price Chart
TickerKWE [NASD]
CompanyKWESST Micro Systems Inc
CountryCanada
IndustryAerospace & Defense
Market Cap2.64MEPS (ttm)-7.37
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-133.75%
P/S1.60EPS next 5Y-
P/B0.59EPS Q/Q-56.34%
Dividend-Sales Q/Q569.83%
Insider Own2.23%Inst Own4.09%
Insider Trans0.00%Inst Trans395.37%
Short Float2.49%EarningsFeb 18/b
Analyst Recom1.00Target Price50.17
Avg Volume5.78M52W Range0.26 - 12.00
KWESST Micro Systems, Inc. provides defense and security services. The firm's technology portfolio includes its proprietary MISST system, Micro Integrated Systems and Software Technology. The company was founded by Jeff Macleod on November 28, 2017, and is headquartered in Ottawa, Canada.
LPRO - Open Lending Corp - Stock Price Chart
TickerLPRO [NASD, RUT]
CompanyOpen Lending Corp
CountryUSA
IndustryCredit Services
Market Cap153.33MEPS (ttm)-1.13
P/E-EPS this Y102.78%
Forward P/E10.67EPS next Y281.81%
PEG-EPS past 5Y17.56%
P/S6.38EPS next 5Y-
P/B1.96EPS Q/Q-2881.28%
Dividend-Sales Q/Q-481.04%
Insider Own9.24%Inst Own69.99%
Insider Trans0.00%Inst Trans0.73%
Short Float2.99%EarningsMar 31/a
Analyst Recom1.83Target Price2.95
Avg Volume1.01M52W Range1.15 - 6.97
Open Lending Corp. provides lending enablement and risk analytics to credit unions, regional banks and the captive finance companies of original equipment manufacturers (OEM Captives). It specializes in risk-based pricing and modeling and provides automated decision-technology for automotive lenders throughout the United States. The firm addresses the financing needs of near-prime and non-prime borrowers, or borrowers with a credit score who are underserved in the automotive finance industry. The company was founded by John J. Flynn, Sandy Watkins and Ross M. Jessup in 2000 and is headquartered in Austin, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Jehl Charles DSee RemarksMar 22 '25Option Exercise0.0070,0280364,799Mar 25 06:53 PM
Stark MatthewSee RemarksMar 15 '25Option Exercise0.0019,271061,309Mar 18 07:42 PM
Roe MatthewChief Revenue OfficerMar 15 '25Option Exercise0.0019,4570155,935Mar 18 07:42 PM
Lackey SarahChief Technology OfficerMar 15 '25Option Exercise0.0018,386087,203Mar 18 07:42 PM
Jehl Charles DSee RemarksMar 15 '25Option Exercise0.0041,2790301,198Mar 18 07:42 PM
OEC - Orion S.A - Stock Price Chart
TickerOEC [NYSE, RUT]
CompanyOrion S.A
CountryLuxembourg
IndustrySpecialty Chemicals
Market Cap712.14MEPS (ttm)0.75
P/E16.81EPS this Y-6.36%
Forward P/E6.10EPS next Y24.97%
PEG1.44EPS past 5Y-12.17%
P/S0.38EPS next 5Y11.67%
P/B1.52EPS Q/Q259.42%
Dividend0.85%Sales Q/Q-7.26%
Insider Own3.93%Inst Own96.99%
Insider Trans0.15%Inst Trans2.21%
Short Float1.27%EarningsFeb 19/a
Analyst Recom1.40Target Price19.60
Avg Volume533.76K52W Range12.51 - 26.05
Orion SA engages in the production and supply of carbon black. It operates through the Specialty Carbon Black and Rubber Carbon Black segments. The Specialty Carbon Black segment manufactures specialty carbon black at multiple sites for a broad range of specialized applications. The Rubber Carbon Black segment is used in the reinforcement of rubber in tires and mechanical rubber goods. Specialties are used as pigments and performance additives in coatings, polymers, printing and special applications. The company was founded on April 13, 2011 and is headquartered in Senningerberg, Luxembourg.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Quinones CarlosSr. VP Global OperationsMar 12 '25Buy13.073,30043,13179,702Mar 13 07:00 PM
Painter Corning F.Chief Executive OfficerAug 22 '24Buy17.6910,000176,900958,776Aug 23 07:41 PM
SMITH DAN FDirectorAug 09 '24Buy18.532,50046,32578,772Aug 12 08:00 PM
Painter Corning F.Chief Executive OfficerAug 07 '24Buy17.4820,000349,671948,776Aug 08 08:01 PM
Glajch JeffreyChief Financial OfficerAug 07 '24Buy18.1615,000272,450101,855Aug 07 08:02 PM
GITS - Global Interactive Technologies Inc - Stock Price Chart
TickerGITS [NASD]
CompanyGlobal Interactive Technologies Inc
CountrySouth Korea
IndustryInternet Content & Information
Market Cap3.09MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B0.29EPS Q/Q83.92%
Dividend-Sales Q/Q-100.00%
Insider Own24.78%Inst Own0.35%
Insider Trans0.00%Inst Trans23.36%
Short Float0.67%Earnings-
Analyst Recom-Target Price-
Avg Volume121.21K52W Range1.17 - 15.00
Global Interactive Technologies, Inc. engages in the provision of a global multi-media platform for users to interact with other like-minded users to share appreciation of various types of entertainment and cultures such as K-POP and modern Korean culture. It operates through the FANTOO platform. The company was founded on October 20, 2021 and is headquartered in Seoul, South Korea.
1456789101112131420